Systemic lupus erythematosus and pregnancy

Current Opinion in Obstetrics and Gynecology

Volumn 18, Issue 6, 2006, Pages 613-617

  Molad, Yair ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Antiphospholipid syndrome; Congenital heart block; Oral contraceptives; Pregnancy; Systemic lupus erythematosus

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; BETA2 GLYCOPROTEIN 1 ANTIBODY; BETAMETHASONE; CARDIOLIPIN ANTIBODY; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEXAMETHASONE; ESTROGEN; ETHINYLESTRADIOL; HEPARIN; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; LA ANTIBODY; LEVONORGESTREL; LOW MOLECULAR WEIGHT HEPARIN; LUPUS ANTICOAGULANT; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT; PREDNISONE; PROGESTERONE; RO ANTIBODY;

AMENORRHEA; ANTIBODY BLOOD LEVEL; ANTIPHOSPHOLIPID SYNDROME; BLEEDING; CLINICAL TRIAL; CONGENITAL HEART BLOCK; CONGENITAL MALFORMATION; DISEASE EXACERBATION; ESTROGEN THERAPY; FERTILIZATION IN VITRO; FETUS OUTCOME; FETUS WASTAGE; HORMONAL THERAPY; HUMAN; HYPERTENSION; LUPUS ERYTHEMATOSUS NEPHRITIS; MATERNAL DISEASE; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; PROTEINURIA; REVIEW; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOEMBOLISM; THROMBOSIS;

AUTOANTIGENS; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; OVULATION INDUCTION; PREGNANCY; PREGNANCY COMPLICATIONS; RIBONUCLEOPROTEINS;

EID: 33751002977     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/GCO.0b013e32800ff5c5     Document Type: Review

References (35)

1. D'Cruz DP. Systemic lupus erythematosus. BMJ 2006; 332:890-894.
2. Bertolaccini ML, Khamashta MA. Laboratory diagnosis and management challenges in the antiphospholipid syndrome. Lupus 2006; 15:172-178.
3. Kyttaris VC, Juang YT, Tsokos GC. Immune cells and cytokines in systemic lupus erythematosus: an update. Curr Opin Rheumatol 2005; 17:518-522. This is a review of recent developments in the field of B and T-cell response in SLE.
4. Doria A, Iaccarino L, Arienti S, et al. Th2 immune deviation induced by pregnancy: the two faces of autoimmune rheumatic diseases. Reprod Toxicol 2006; 22:234-241. This is a recent review on the Th2-cytokine immunologic modulation of autoimmune diseases such as SLE.
5. Petri M, Kim MY, Kalunian KC, et al., for the OC-SALENA Trial. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 2005; 353:2550-2558.
6. Sánchez-Guerrero J, Uribe AG, Jiménez-Santana L, et al. A trial of contraceptive methods in women with systemic lupus erythematosus. N Engl J Med 2005; 353:2539-2549.
7. Buyon JP, Petri MA, Kim MY, et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: A randomized trial. Ann Intern Med 2005; 142:953-962.
8. Manger K, Wildt L, Kalden JR, Manger B. Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated with cyclophosphamide: The PREGO-Study. Autoimmun Rev 2006; 5:269-272.
9. Guballa N, Sammaritano L, Schwattzman S, et al. Ovulation induction and in-vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome. Arthritis Rheum 2000; 43:550-556.
10. Huong DLT, Wechsler B, Vauthier-Brouzes D, et al. Importance of planning ovulation induction therapy in systemic lupus erythematosus and antiphospholipid syndrome: A single center retrospective study of 21 cases and 114 cycles. Semin Arthritis Rheum 2002; 32:174-188.
11. Yinon Y, Pauzner R, Dulitzky M, et al. Safety of IVF under anticoagulant therapy in patients at risk for thromboembolic events. Reprod Biomed Online 2006; 12:354-358.
12. Molad Y, Borkowski T, Monselise A, et al. Maternal and fetal outcome of lupus pregnancy: a prospective study of 29 pregnancies. Lupus 2005; 14:145-151. A prospective study that covers all aspects of lupus pregnancy and comprehensively reviews past publications.
13. Chakravarty EF, Nelson L, Krishman E. Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 2006; 54:899-907.
14. Germain S, Nelson-Piercy C. Lupus nephritis and renal disease in pregnancy. Lupus 2006; 15:148-155.
15. Rahman FZ, Rahman J, Al-Suleiman A, Rahman MS. Pregnancy outcome in lupus nephropathy. Arch Gynecol Obstet 2005; 271:222-226.
16. McGrory CH, McCloskey LJ, DeHoratius RJ, et al. Pregnancy outcomes in female renal recipients: A comparison of systemic lupus erythematosus with other diagnoses. Am J Transplant 2003; 3:35-42.
17. Clark CA, Spitzer KA, Laskin CA. Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period. J Rheumatol 2005; 32:1709-1712.
18. Egerman RS, Ramsey RD, Kao LW, et al. Hypertensive disease in pregnancies complicated by systemic lupus erythematosus. Am J Obstet Gynecol 2005; 193:1676-1679.
19. Chakravarty EF, Colón I, Langen ES, et al. Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obstet Gynecol 2005; 192:1897-1904.
20. Dhar JP, Essenmacher LM, Ager JW, Sokol RJ. Pregnancy outcomes before and after a diagnosis of systemic lupus erythematosus. Am J Obstet Gynecol 2005; 193:1444-1455.
21. Clowse MEB, Magder LS, Witter F, Petri M. Early risk factors for pregnancy loss in lupus. Obstet Gynecol 2006; 107:293-299.
22. Ruiz-Irastorza G, Khamashta MA. Management of thrombosis in antiphospholipid syndrome and systemic lupus erythematosus in pregnancy. Ann N Y Acad Sci 2005; 1051:606-612. This is a comprehensive review of the management of APLA-associated complications during pregnancy.
23. Sailer T, Zoghlami C, Kurz C, et al. Antibeta2-glycoprotein I antibodies are associated with pregnancy loss in women with the lupus anticoagulant. Thromb Haemost 2006; 95:796-801.
24. Lim W, Crowther MA, Eikelboom JW. Management of antiphospholipid antibody syndrome: a systematic review. JAMA 2006; 295:1050-1057. The authors present a systematic review on all aspects of the diagnosis and management of APLA syndrome.
25. Le Thi Thuong D, Tieulie N, Costedoat N, et al. The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women. Ann Rheum Dis 2005; 64:273-278.
26. Buyon JP, Hiebert R, Copel J, et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a National Neonatal Lupus Registry. J Am Coll Cardiol 1998; 31:1658-1666.
27. Brucato A, Doria A, Frassi M, et al. Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SS-A antibodies: a prospective controlled study. Lupus 2002; 11:716-721.
28. Glickstein JS, Buyon J, Friedman D. Pulsed Doppler echocardiographic assessment of the fetal PR interval. Am J Cardiol 2000; 86:236-239.
29. Salmonsson S, Sonesson SE, Ottosson L, et al. Ro/SS-A autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block. J Exp Med 2005; 201:11-17.
30. Clancy RM, Buyon JP, Ikeda K, et al. Maternal antibody responses to the 52-kD SSA/Ro p200 peptide and the development of fetal conduction defects. Arthritis Rheum 2005; 52:3079-3086.
31. Clancy RM, Kapur RP, Molad Y, et al. Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage/fibroblast crosstalk in the pathologic cascade leading to congenital heart block. Arthritis Rheum 2004; 50:173-182.
32. Buyon JP, Clancy RM. Maternal autoantibodies and congenital heart block: mediators, markers, and therapeutic approach. Semin Arthritis Rheum 2003; 33:140-154.
33. Costedoat-Chalumeau N, Amoura Z, Le Thi Huong D, et al. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: Review of the literature. Autoimmun Rev 2005; 4:111-115.
34. Ostensen M, Khamashta M, Lockshin M, et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 2006; 8:209. This presents recommendations on the safety of anti-inflammatory and immunosuppressive drugs during pregnancy and lactation, based on a consensus workshop of international experts.
35. Clowse ME, Magder L, Petri M. Cyclophosphamide for lupus during pregnancy. Lupus 2005; 14:593-597.